The HBCU Cancer Trials Consortium
The HBCU Cancer Trials Consortium
The HBCU CTC is a network of HBCUs and dedicated Allies
with a dual mission:
-- Bring the power of innovative cancer clinical trials to historically underserved communities.
-- Honor and build on the legacy of HBCUs, which have consistently and successfully served underserved populations for over a century.
- facilitate and oversee cancer clinical trial conduct
in underserved populations
- develop local clinical trial infrastructure
at member institutions
Charles R. Drew College of Medicine
Howard University College of Medicine
Meharry Medical College
Morehouse School of Medicine
Sheldon L. Holder, MD, PhD
Executive Director
HBCU Cancer Trials Consortium (HBCU-CTC)
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.